AUG 01, 2021 9:32 AM PDT

New Compound Halts Neurodegeneration in Alzheimer's

WRITTEN BY: Annie Lennon

Chemists have synthesized new compounds that can halt neurodegeneration linked to Alzheimer’s and other neurological conditions. The study was published in the European Journal of Medicinal Chemistry by researchers from the Russian Academy of Sciences. 

Alzheimer’s disease is characterized by a build-up of amyloid plaques in the brain. This build-up reduces synaptic communication, which results in the cognitive symptoms associated with Alzheimer’s. 

Previous research has found that people with Alzheimer’s tend to have low levels of heat shock proteins (HSPs), which are key for preventing protein misfolding and aggregation. Hsp90 inhibitors, in particular, are thought to regulate the activity of the transcription factor heat shock factor (HSF-1), as well as Hsp70, and thus protect against the over-accumulation of harmful proteins.

“Our compounds activate the synthesis of specific heat shock proteins and cause their accumulation in the cell,” said Irina Utepova, one of the researchers behind the study. 

“Proteins of this type make it possible to protect neuronal tissue from an excess of toxic amyloids and to protect cells from various types of stress, including proteotoxic stress characteristic of neurodegenerative diseases,” she continued. 

For the study, the researchers synthesized a group of pyrrolyl- and indolylaznes via photocatalysis that cause heat shock proteins to accumulate. In cells models of both Alzheimer's disease and traumatic brain injury, they found that the compounds were able to increase the survival of neuronal cells. 

The researchers then tested the most effective of these compounds on live rat tissues with secondary injuries from traumatic brain injury. Use of the drug, say the researchers, prevented the appearance of movement disorders and degeneration among hippocampal neurons. 

The researchers are currently conducting further research on the mechanism of action for their new compounds in preparation for preclinical tests. 

 

Sources: European Journal of Medicinal ChemistryPMCBiomed Research InternationalNeuroscience News

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 16, 2022
Drug Discovery & Development
Oxytocin Nasal Sprays Don't Improve Emotion Recognition in Healthy Individuals
JUL 16, 2022
Oxytocin Nasal Sprays Don't Improve Emotion Recognition in Healthy Individuals
Oxytocin nasal sprays do not improve the recognition of emotions such as anger and sadness in healthy men without autism ...
AUG 23, 2022
Clinical & Molecular DX
By Targeting the Cause of the Disease, a Potential Long-Term Treatment for Asthma is Found
AUG 23, 2022
By Targeting the Cause of the Disease, a Potential Long-Term Treatment for Asthma is Found
Asthma is a disease that affects the lungs, causing symptoms of wheezing, tightness in the chest, and shortness of breat ...
AUG 15, 2022
Drug Discovery & Development
New Drug Candidate Treats Over 300 Drug Resistant Bacteria
AUG 15, 2022
New Drug Candidate Treats Over 300 Drug Resistant Bacteria
Researchers have identified a new molecule that shows promise in inhibiting over 300 drug-resistant bacteria, including ...
AUG 22, 2022
Drug Discovery & Development
A quick fix for depression? Axsome Therapeutics develops fast-acting drug to treat major depressive disorder.
AUG 22, 2022
A quick fix for depression? Axsome Therapeutics develops fast-acting drug to treat major depressive disorder.
Major depressive disorder (MDD) is a common mental health disorder. Recent data from the National Institute of Ment ...
AUG 30, 2022
Cannabis Sciences
Research Highlights the Training Needs of Cannabis Dispensary Staff
AUG 30, 2022
Research Highlights the Training Needs of Cannabis Dispensary Staff
A new study published in JCO Oncology Practice, and conducted by researchers at Dana-Farber Cancer Institute, found unev ...
SEP 23, 2022
Cannabis Sciences
Cannabis Legalization's Impact on Pharmaceutical Stock Market Values
SEP 23, 2022
Cannabis Legalization's Impact on Pharmaceutical Stock Market Values
In states with legal medical cannabis, people are curious about using cannabinoid treatment as an alternative to pharmac ...
Loading Comments...